MAR
69
-3
CSCO
61
-6
MLM
51
-6
MDT
57
-2
MUR
48
3
O
30
-3
CAH
54
-6
PEP
50
2
TXT
58
-4
BMY
63
2
CTSH
63
-2
SE
57
-3
MSI
76
-3
CHD
50
2
TSN
50
2
KIM
70
-3
HON
70
-3
SPG
60
-3
WYNN
41
9
PBI
59
-6
MAR
69
-3
CSCO
61
-6
MLM
51
-6
MDT
57
-2
MUR
48
3
O
30
-3
CAH
54
-6
PEP
50
2
TXT
58
-4
BMY
63
2
CTSH
63
-2
SE
57
-3
MSI
76
-3
CHD
50
2
TSN
50
2
KIM
70
-3
HON
70
-3
SPG
60
-3
WYNN
41
9
PBI
59
-6
Financhill
Back

Mackenzie All-Equity Allocation ETF Vs. Dyne Therapeutics Industry Stock Comparison

Sell
32

MEQT.TO
Mackenzie All-Equity Allocation ETF

Last Price:
25.29
Seasonality Move:
--
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
32
Mackenzie All-Equity Allocation ETF (MEQT.TO) is a Sell

Is Mackenzie All-Equity Allocation ETF a Buy, Sell or Hold?

  • The current Mackenzie All-Equity Allocation ETF [MEQT.TO] share price is $25.29. The Score for MEQT.TO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • MEQT.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MEQT.TO Stock Price Chart

What is Mackenzie All-Equity Allocation ETF's stock price today?

  • The Mackenzie All-Equity Allocation ETF share price today is $25.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEQT.TO is experiencing slight buying pressure.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

MEQT.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 67.84 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.73 - 25.19) Buy
Bollinger Bands (100): (23.12 - 24.64) Buy

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

MEQT.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.17 Buy
20-day SMA: 24.98 Buy
50-day SMA: 24.44 Buy
200-day SMA: 23.04 Buy
8-day EMA: 25.17 Buy
20-day EMA: 24.97 Buy
50-day EMA: 24.54 Buy
200-day EMA: 23.02 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

Mackenzie All-Equity Allocation ETF Earnings Growth & MEQT.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

Mackenzie All-Equity Allocation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):